Summary
Four catalytic inhibitors of GABA-aminotransferase (GABA-T), viz. gabaculine, γ-acetylenic GABA, γ-vinyl GABA, and ethanolamine O-sulphate (EOS), as well as the unspecific enzyme inhibitor aminooxyacetic acid (AOAA), sodium valproate (VPA), and GABA itself were studied for anticonvulsant, biochemical, and toxic effects in mice. Elevations of the electroconvulsive threshold by 30 V were produced at the time of their maximal effect by the i.p. injection (AOAA s.c.) of 13 mg/kg AOAA, 37 mg/kg gabaculine, 65mg/kg γ-acetylenic GABA, 125 mg/kg VPA, 1,440 mg/kg EOS, 1,900 mg/kg γ-vinyl GABA and 2,800 mg/kg GABA. At these doses, all drugs except GABA and VPA increased the clonic pentetrazole threshold to a similar extent, but differed in their increases in the brain content of GABA, which varied from 70% (EOS) to 300% (γ-vinyl GABA) as a consequence of decreases in the activity of GABA-T. The activity of the GABA-synthesizing enzyme glutamate decarboxylase was decreased only by γ-acetylenic GABA. When determining the anticonvulsant effect of the different drugs against the convulsant ED 97 of pentetrazole, 3-mercaptopropionic acid, strychnine and maximal electroshock seizures, gabaculine, AOAA, VPA and in part γ-vinyl GABA and GABA were efficacious enough to allow the determination f ED50 values, whereas γ-acetylenic GABA and EOS showed no clear activity in any of these seizure models.
Gabaculine and AOAA at their anticonvulsant ED50 were toxic or lethal. All inhibitors of GABA-T except EOS caused numerous side effects which cast doubt on the specificity of these drugs. The present results indicate that inhibitors of GABA-T hardly seem to be suited for treatment of convulsive disorders in human but are useful tools in studies of experimental epilepsy.
Similar content being viewed by others
References
Baxter MG, Fowler LJ, Miller AA, Walker JMG (1973) Some behavioural and anticonvulsant actions in mice of ethanolamine O-sulphate, an inhibitor of 4-aminobutyrate-aminotransferase. Br J Pharmacol 47: 681P
Boissier J-R, Tardy J, Diverres J-C (1960) Une nouvelle méthode simple pour explorer l'action “tranquillisante”: le test de la Cheminée. Med Exp (Basel) 3:81–84
Da Vanzo JP, Matthews RJ, Stafford JE (1964) Studies on the mechanism of action of aminooxyacetic acid. I. Reversal of aminooxyacetic acid-induced convulsions by various agents. Toxicol Appl Pharmacol 6:388–395
Dunham NW, Miya TS (1957) A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc 46:208–209
Fisher R, Norris JW, Gilka L (1974) GABA in Huntington's chorea. Lancet I:506
Fletcher A, Fowler LJ (1980) Some neurochemical effects of chronic oral administration of ethanolamine O-sulphate to rats. Br J Pharmacol 68:130–131P
Fowler LJ (1973) Analysis of the major amino acids of rat brain after in vivo inhibition of GABA transaminase by ethanolamine O-sulphate. J Neurochem 21:437–440
Fowler LJ, John RA (1972) Active-site-directed irreversible inhibition of rat brain 4-aminobutyrate aminotransferase by ethanolamine O-sulphate in vitro and in vivo. Biochem J 130:569–573
Frey HH, Löscher, W (1980) Cetyl GABA: Effect on convulsant threshold in mice and acute toxicity. Neuropharmacology 19:217–220
Frey H-H, Popp C, Löscher W (1979) Influence of inhibitiors of the high affinity GABA uptake on seizure thresholds in mice. Neuropharmacology 18:581–590
Gent JP, Normanton JR (1978) Actions of γ-acetylenic GABA on single central neurones in rat. Br J Pharmacol 64:383–384P
Hill RG, Simmonds MA, Straughan DW (1976) Antagonism of γ-aminobutyric acid and glycine by convulsants in the cuneate nucleus of cat. Br J Pharmacol 56:9–19
Hint HC, Richter AW (1958) A simple intravenous infusion technique for mice. Acta Pharmacol Toxicol (Kbh) 14:153–157
Horton RW, Anlezark GM, Sawaya MCB, Meldrum BS (1977) Monoamine and GABA metabolism and the anticonvulsant action of di-n-propylacetate and ethanolamine-O-sulphate. Eur J Pharmacol 41:387–397
Iadarola MJ, Gale K (1979) Dissociation between drug-induced increases in nerve terminal and non-nerve terminal pools of GABA in vivo. Eur J Pharmacol 59:125–129
John RA, Jones ED, Fowler LJ (1979) Enzyme-induced inactivation of transaminases by acetylenic and vinyl analogues of 4-aminobutyrate. Biochem J 177:721–728
Jung MJ, Seiler N (1978) Enzyme-activated irreversible inhibitors of l-ornithine: 2-oxoacetic aminotransferase. Demonstration of mechanistic features of the inhibition of ornithine aminotransferase by 4-aminohex-5-ynoic acid and gabaculine and correlation with in vivo activity. J Biol Chem 253:7431–7439
Kimball AW, Burnett WT, Doherty DG (1957) Sampling methods for screening compounds in radiation protection studies with mice. Radiat Res 7:1–12
Leach MJ, Walker JMG (1977) Effect of ethanolamine-O-sulphate on regional GABA metabolism in the mouse brain. Biochem Pharmacol 26:1569–1572
Litchfield JT, Wilcoxon F (1949) A simplified method of evaluating dose-effect experoments. J Pharmacol Exp Ther 96:99–113
Lloyd KG, Worms P, Depoortere H, Bartholini G (1979) Pharmacological profile of SL 76002, a new GABA-mimetic drug. In: Krogsgaard-Larsen P, Scheel-Krüger J, Kofod H (eds) GABA-Neurotransmitters. Mungsgaard, Copenhagen, p 308–325
Löscher W (1979) 3-Mercaptopropionic acid: Convulsant properties, effects on enzymes of the γ-aminobutyrate system in mouse brain and antagonism by certain anticonvulsant drugs, aminooxyacetic and gabaculine. Biochem Pharmacol 28:1397–1407
Löscher W (1980a) Effect of inhibitors of GABA transaminase on the synthesis, binding, uptake, and metabolism of GABA. J Neurochem 34:1603–1608
Löscher W (1980b) Zum Wirkungsmechanismus der Antiepileptika. Tierexperimentelle Befunde zur Bedeutung von Neurotransmittern. Nervenarzt (in press)
Löscher W, Frey H-H (1977a) Effect of convulsant and anticonvulsant agents on level and metabolism of γ-aminobutyric acid in mouse brain. Naunyn-Schmiedeberg's Arch Pharmacol 296:263–269
Löscher W, Frey, H-H (1977b) Zum Wirkungsmechanismus von Valproisäure. Arzneim Forsch 27:1081–1082
Löscher W, Frey H-H (1978) Aminooxyacetic acid: Correlation between biochemical effects, anticonvulsant action and toxicity in mice. Biochem Pharmacol 27:103–108
Lowe IP, Robins E, Eyerman GS (1958) The fluorimetric measurement of glutamic acid decarboxylase and its distribution in brain. J Neurochem 3:8–18
McGeer PL, McGeer EG, Wada JA (1971) Glutamic acid decarboxylase in parkinson's disease and epilepsy. Neurology 21:1000–1007
Meldrum BS (1975) Epilepsy and GABA-mediated inhibition. Int Rev Neurobiol 17:1–36
Meldrum BS (1975) Gamma-aminobutyric acid and the search for new anticonvulsant drugs. Lancet II:304–306
Metcalf BW (1979) Inhibitors of GABA metabolism. Biochem Pharmacol 28:1705–1712
Perry TL, Hansen S (1973) Sustained drug-induced elevation of brain GABA in the rat. J Neurochem 21:1167–1175
Perry TL, Hansen S (1978) Biochemical effects in man and rat of three drugs which can increase brain GABA content. J Neurochem 30:679–684
Perry TL, Hansen S, Kloster M (1973) Huntington's chorea. Deficiency of γ-aminobutyric acid in brain. N Engl J Med 288:337–342
Perry TL, Kish SJ, Hansen S (1979a) γ-Vinyl-GABA: Effects of chronic administration on the metabolism of GABA and other amino compounds in rat brain. J Neurochem 32:1641–1645
Perry TL, Kish SJ, buchanan J, Hansen S (1979b) γ-Aminobutyric-acid deficiency in brain of schizophrenic patients. Lancet I:237–239
Rodriguez de Lores Arnaiz G, Alberici de Canal M, Robiolo B, Mistrorigo de Pacheco M (1973) The effect of the convulsant 3-mercaptopropionic acid on enzymes of the γ-aminobutyrate system in the rat cerebral cortex. J Neurochem 21:615–623
Salvador RA, Albers RW (1959) The distribution of glutamic-γ-aminobutyric transaminase in the nervous system of the rhesus monkey. J Biol Chem 234:922–925
Sarhan S, Seiler N (1979) Metabolic inhibition and subcellular distribution of GABA. J Neurosci Res 4:398–421
Schechter PJ, Tranier Y (1978) The pharmacology of enzyme-activated inhibitors of GABA-transaminase. In: Seiler N, Jung MJ, Koch-Weser J (eds) Enzyme activated irreversible inhibitors. Elsevier, Amsterdam New York Oxford, p 149–162
Schechter PJ, Tranier Y, Jung MJ, Böhlen P (1977a) Audiogenic seizure protection by elevated brain GABA concentration in mice: Effects of γ-acetylenic GABA and γ-vinyl GABA, two irreversible GABA-T inhibitors. Eur J Pharmacol 45:319–328
Schechter PJ, Tranier Y, Jung MJ, Sjoerdsma A (1977b) Antiseizure activity of γ-acetylenic γ-aminobutyric acid: A catalytic irreversible inhibitor of γ-aminobutyric acid transaminase. J Pharmacol Exp Ther 201:606–612
Schechter PJ, Tranier Y, Grove J (1978) Effect of n-diproyl acetate on amino acid concentrations in mouse brain: correlations with anti-convulsant activity. J Neurochem 31:1325–1327
Schechter PJ, Tranier Y, Grove J (1979) Gabaculine and isogabaculine: In vivo biochemistry and pharmacology in mice. Life Sci 24:1173–1182
Swinyard EA (1949) Laboratory assay of clinically effective antiepileptic drugs. J Amer Pharm Assoc 38:201–204
Tower DB (1960) The administration of gamma-aminobutyric acid to man: systemic effects and anticonvulsant action. In: Roberts E (ed) Inhibition in the nervous system and gammaaminobutyric acid. Pergamon Press, New York, p 562–578
Van Gelder NM, Elliot KAC (1958) Disposition of γ-aminobutyric acid administered to mammals. J Neurochem 3:139–143
Wood JD, Kurylo E, Newstead JD (1978) Aminooxyacetic acid induced changes in γ-aminobutyrate metabolism at the subcellular level. Can. J Biochem 56:667–672
Wood JD, Kurylo E, Sooi-Kay Tsui D (1979) Inhibition of aminotransferase enzyme systems by gabaculine. Neurosci Lett 14:327–331
Author information
Authors and Affiliations
Additional information
Supported by Deutsche Forschungsgemeinschaft (“Research in Epilepsy” program)
Rights and permissions
About this article
Cite this article
Löscher, W. A comparative study of the pharmacology of inhibitors of GABA-metabolism. Naunyn-Schmiedeberg's Arch. Pharmacol. 315, 119–128 (1980). https://doi.org/10.1007/BF00499254
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00499254